Breast Cancer Therapies
Palbociclib
BPT-1205 · Capsule
What is it used for?
Blocks CDK4/6 proteins involved in cell division. Used with specified endocrine therapy for hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer; it is not a general treatment for every breast cancer.
- Dosage form
- Capsule
- Listed strengths
- 125 mg
- Listed pack size
- 21's
- Mechanism
- CDK4/6 inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- HR-positive, HER2-negative advanced or metastatic breast cancer, with endocrine therapy
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information
